Updates

OrchidPharm~~ -- A Dhanuka Group Company ---------------------------------- July 25, 2026 National Stock Exchange of India Limited, BSE Limited Exchange Plaza, Bandra Kurla Complex, Phiroze Jeejeebhoy Towers Bandra (E), Mumbai-400051 Dalal Street, Fort, Mumbai-400001 Symbol: ORCHPHARMA Scrip Code: 524372 Ref: Intimation under Regulation 30 read with Schedule III of Securities and Exchange Board of India (Listing Obligations and Disclosure Reguirements) Regulations, 2015, as amended Sub: Investor Roadshow Scheduled to be held in Singapore. Dear Sir/Madam, Pursuant to Regulation 30 read with Schedule III of Securities and Exchange Board of India (Listing Obligations and Disclosure ReqUirements) Regulations, 2015, as amended, this is to inform that Mr. Mridul Dhanuka, Whole Time Director of Orchid Pharma Limited ("the Company") will be participating in the Investor Roadshow scheduled to be held as per the details mentioned hereunder: Day & Date Meeting Type Mode Place Wednesday, July 29, 2026 Group Meet Physical Singapore Thursday, July 30, 2026 Friday, July 31, 2026 Kindly note that the above schedule may undergo change due to unforeseen exigencies on the part of Investors/Company, which will be informed, if any. Further to inform you that no Unpublished Price Sensitive Information is proposed to be shared by the Company during the aforesaid Investor Meet. We request you to take the above intimation on records. Thanking You, For Orchid Pharma Limited Kapil Dayya Company Secretary & Compliance Officer Membership No.: F10698 +91-44-27444471/72/73 corporate@orchidpharma.com orchidpharma.com CIN: L24222TN1992PLC022994 Registered Office: Corporate Office: Orchid Pharma Limited 15th Floor, Tower 1. DLF Corporate Greens, Sector 74A. Plot Nos. 121-128, 128A-133, 138-151. 159-164, SIDCO Industrial Estate, Gurugram - 122004, Haryana, India Alathur, Chengalpattu Dist - 603110, Tamil Nadu, India.